CINECA IRIS Institutional Research Information System

BOCCHIO CHIAVETTO, LUISELLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.407
EU - Europa 6.666
AS - Asia 1.511
AF - Africa 255
SA - Sud America 84
Continente sconosciuto - Info sul continente non disponibili 22
OC - Oceania 4
Totale 16.949
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.273
RU - Federazione Russa 3.382
DE - Germania 1.495
CN - Cina 727
UA - Ucraina 608
SG - Singapore 582
SE - Svezia 285
GB - Regno Unito 249
CM - Camerun 236
FR - Francia 155
IT - Italia 147
FI - Finlandia 132
CA - Canada 122
IE - Irlanda 94
TR - Turchia 87
PL - Polonia 84
BR - Brasile 68
IN - India 29
EU - Europa 22
VN - Vietnam 17
HK - Hong Kong 12
ES - Italia 10
IL - Israele 8
MX - Messico 8
BD - Bangladesh 6
ID - Indonesia 6
ZA - Sudafrica 6
IR - Iran 5
MA - Marocco 5
PE - Perù 5
SA - Arabia Saudita 5
AR - Argentina 4
HU - Ungheria 4
JP - Giappone 4
AE - Emirati Arabi Uniti 3
AT - Austria 3
BE - Belgio 3
LT - Lituania 3
AM - Armenia 2
AU - Australia 2
BO - Bolivia 2
DZ - Algeria 2
EC - Ecuador 2
JO - Giordania 2
KE - Kenya 2
KZ - Kazakistan 2
MY - Malesia 2
NL - Olanda 2
PK - Pakistan 2
RO - Romania 2
AZ - Azerbaigian 1
BB - Barbados 1
BF - Burkina Faso 1
BY - Bielorussia 1
CH - Svizzera 1
CO - Colombia 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GE - Georgia 1
GR - Grecia 1
IQ - Iraq 1
KI - Kiribati 1
KR - Corea 1
KY - Cayman, isole 1
LY - Libia 1
MN - Mongolia 1
NO - Norvegia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PH - Filippine 1
PT - Portogallo 1
PY - Paraguay 1
SC - Seychelles 1
TH - Thailandia 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
UZ - Uzbekistan 1
VE - Venezuela 1
Totale 16.949
Salva come PNG Salva come JPEG
Città #
Fairfield 1.564
Woodbridge 699
Ashburn 698
Seattle 696
Houston 661
Beijing 636
Cambridge 604
Jacksonville 560
Chandler 539
Wilmington 504
Moscow 304
Ann Arbor 213
Singapore 184
The Dalles 110
Ottawa 106
Boardman 103
Chicago 95
Dublin 91
Lawrence 90
Princeton 86
New York 74
Kraków 65
Helsinki 64
Rome 61
London 51
San Diego 49
Saint Petersburg 35
Los Angeles 32
Dallas 31
Frankfurt am Main 31
Portsmouth 28
Yubileyny 25
Lauterbourg 19
Nanjing 17
Norwalk 16
Prescot 16
San Francisco 14
Cedar Knolls 13
Kunming 13
Redwood City 13
Chiswick 12
Guangzhou 12
Hong Kong 11
Warsaw 11
Düsseldorf 10
Milan 10
Mumbai 10
Hefei 9
Islington 9
Kilburn 9
Roubaix 9
Atlanta 8
Dearborn 8
Hounslow 8
Falls Church 7
Mcallen 7
Mexico City 7
Wroclaw 7
Hanoi 6
Johannesburg 6
Boston 5
Brooklyn 5
Chengdu 5
Council Bluffs 5
Ho Chi Minh City 5
Nanchang 5
Redmond 5
St Louis 5
St Petersburg 5
Stockholm 5
São Paulo 5
Bexley 4
New Bedfont 4
Santa Clara 4
Shanghai 4
Toronto 4
West Jordan 4
Ankara 3
Brussels 3
Caxias do Sul 3
Chennai 3
Guarulhos 3
Istanbul 3
Jinan 3
Kocaeli 3
Manchester 3
Munich 3
Porto Alegre 3
Rimini 3
Rio de Janeiro 3
Riyadh 3
Segrate 3
Shenyang 3
Sotto 3
The Bronx 3
Tokyo 3
Almaty 2
Assago 2
Barcelona 2
Behshahr 2
Totale 9.530
Salva come PNG Salva come JPEG
Nome #
The -1727 A/T, -50 C/T and (CAA)(n) repeat GSK-3 beta gene polymorphisms and resistance to antipsychotics in schizophrenia 450
Immune and metabolic alterations in first episode psychosis (FEP) patients 370
Association between baseline serum vascular endothelial growth factor levels and response to electroconvulsive therapy. 322
Peripheral whole blood microRNA alterations in major depression and bipolar disorder 282
Absolute Measurements of Macrophage Migration Inhibitory Factor and Interleukin-1-β mRNA Levels Accurately Predict Treatment Response in Depressed Patients 280
Inflammation and neuronal plasticity: a link between childhood trauma and depression pathogenesis 279
BDNF serum levels, but not BDNF Val66Met genotype, are correlated with personality traits in healthy subjects 278
Allelic variation in the human prodynorphin gene promoter and schizophrenia 261
Effect of repetitive transcranial magnetic stimulation on serum brain derived neurotrophic factor in drug resistant depressed patients 252
Association between the BDNF 196 A/G polymorphism and sporadic Alzheimer's disease 248
Alzheimer's disease cerebrospinal fluid biomarker in cognitively normal subjects. 248
Serum leptin levels are higher in females affected by frontotemporal lobar degeneration than Alzheimer's disease 246
Promoter haplotypes of interleukin-10 gene and sporadic Alzheimer's disease 246
Aspetti biologici e neuropsicologici del maltrattamento e abuso infantili 242
Effetti biomolecolari del maltrattamento infantile: il ruolo dell'epigenetica e dell'infiammazione 242
-G308A tumor necrosis factor alpha functional polymorphism and schizophrenia risk: Meta-analysis plus association study 239
Serum levels of brain-derived neurotrophic factor in drug-naive obsessive-compulsive patients: A case-control study 236
BDNF Val66Met polymorphism and protein levels in Amniotic Fluid 233
Serum and plasma BDNF levels in major depression: A replication study and meta-analyses 228
Abnormal levels of cAMP-dependent protein kinase regulatory subunits in platelets from schizophrenic patients 228
5-HTTLPR and BDNF Val66Met polymorphisms and response to rTMS treatment in drug resistant depression 228
Alterations of Brain-Derived Neurotrophic Factor Serum Levels in Patients with Alcohol Dependence 224
Distinct cerebrospinal fluid amyloid-beta peptide signatures in cognitive decline associated with Alzheimer's disease and schizophrenia 222
Glucose metabolism alterations in patients with bipolar disorder 222
Validation of a quantitative cerebrospinal fluid alpha-synuclein assay in a European-wide interlaboratory study 221
Nanomedicine in Psychiatry: New Therapeutic Opportunities from Research on Small RNAs 219
Haptoglobin polymorphism and schizophrenia: Genetic variation on chromosome 16 218
Electroconvulsive Therapy (ECT) increases serum Brain Derived Neurotrophic Factor (BDNF) in drug resistant depressed patients 218
Association between promoter polymorphic haplotypes of interleukin-10 gene and schizophrenia 217
Cerebrospinal fluid markers for Alzheimer's disease in a cognitively healthy cohort of young and old adults. 217
Serum Levels of Insulin-Like Growth Factor-1 and Obsessive-Compulsive Disorder: A Case-Control Study 216
Micro spies from the brain to the periphery: new clues from studies on microRNAs in neuropsychiatric disorders. 215
Insulin-like growth factor binding protein 2 in bipolar disorder: An expression study in peripheral tissues 215
BDNF Genotype and Baseline Serum Levels in Relation to Electroconvulsive Therapy Effectiveness in Treatment-Resistant Depressed Patients 209
Increased serum interleukin-8 and interleukin-10 in schizophrenic patients resistant to treatment with neuroleptics and the stimulatory effects of clozapine on serum leukemia inhibitory factor receptor 208
Altered gene expression in schizophrenia: findings from transcriptional signatures in fibroblasts and blood 208
miR-146a and miR-181a are involved in the progression of mild cognitive impairment to Alzheimer's disease 207
Reduced peripheral brain-derived neurotrophic factor mRNA levels are normalized by antidepressant treatment 205
Blood microRNA changes in depressed patients during antidepressant treatment 204
Season of birth and inflammatory response system in schizophrenia 203
Markers of Alzheimer's disease in a population attending a memory clinic 202
Blood microRNA longitudinal changes in depressed patients during antidepressant treatment 202
A multi-element psychosocial intervention for early psychosis (GET UP PIANO TRIAL) conducted in a catchment area of 10 million inhabitants: study protocol for a pragmatic cluster randomized controlled trial 202
Vascular Endothelial Growth Factor (VEGF) serum concentration during electroconvulsive therapy (ECT) in treatment resistant depressed patients 202
Influence of serotonin receptor 2A His452Tyr polymorphism on brain temporal structures: a volumetric MR study 200
Study of the in vitro modulation exerted by the antidepressant drug escitalopram on the expression of candidate microRNAs and their target genes 196
Effect of the XbaI polymorphism of estrogen receptor alpha on postmenopausal gray matter 195
Effects of Intranasal Oxytocin on Long-Term Memory in Healthy Humans: A Systematic Review 195
Lack of association between MnSOD gene polymorphism and sporadic Alzheimer's disease 194
G308A tumor necrosis factor alpha functional polymorphism and schizophrenia risk: Meta-analysis plus association study 194
VEGF serum levels in depressed patients during SSRI antidepressant treatment 193
Serum brain-derived neurotrophic factor (BDNF) levels in attention deficit-hyperactivity disorder (ADHD) 192
Neurobiological and clinical effect of metacognitive interpersonal therapy vs structured clinical model: study protocol for a randomized controlled trial 191
The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkers 190
Effects of atypical antipsychotics on the inflammatory response system in schizophrenic patients resistant to treatment with typical neuroleptics 187
Serum Brain-Derived Neurotrophic Factor Levels in Different Neurological Diseases 186
Influence of clotting duration on brain-derived neurotrophic factor (BDNF) dosage in serum. 184
Supporting evidence for using biomarkers in the diagnosis of MCI due to AD 182
Serum brain-derived neurotrophic factor (BDNF) levels in attention deficit-hyperactivity disorder (ADHD) 179
No occurrence of the glutamate transporter EAAT2 A206G polymorphism in schizophrenic subjects 170
Analysis of miRNome expression profiles in hippocampus of rats treated with antidepressants 161
Correlations between immune and metabolic serum markers and schizophrenia/bipolar disorder polygenic risk score in first-episode psychosis 157
Association study of-1727 A/T,-50 C/T and (CAA)(n) repeat GSK-3 beta gene polymorphisms with schizophrenia 150
Association study and meta-analysis of-308 A/G functional polymorphism in TNF alpha gene with schizophrenia 147
Association between IL-1 cluster and IL-10 gene polymorphisms and schizophrenia 147
Gene-environment interaction in major depression: focus on experience-dependent biological systems 147
Association between IL-1 beta-511C/T and IL-1RA (86bp)n repeats polymorphisms and schizophrenia 147
CYP2D6 polymorphism in patients with Alzheimer's disease in treatment with cholinesterase inhibitors 144
Association study between -1727A/T, -50C/T and (CAA)(N) repeat GSK-3beta gene polymorphisms and Bipolar Disorder 143
The cytokine network genes and resistance to antipsychotics in schizophrenia 137
Influence of G1730A polymorphism of estrogen receptor beta gene on brain morphology in postmenopausal women 136
Peripheral BDNF levels and personality traits in a sample of subjects non affected by psychiatric diseases 133
Evidence in Support of the AD Biomarker Dynamic Model from a Memory Clinic Naturalistic Series of Patients with Mild Cognitive Impairment 132
Childhood trauma and glucose metabolism in patients with first-episode psychosis 130
Serum brain derived neurotrophic factor concentrations in attention deficit hyperactivity disorder (ADHD) 129
Brain-derived neurotrophic factor as potential diagnostic biochemical marker of depressive state 128
Serum and plasma BDNF levels in major depression: Replication study plus meta-analysis 125
miR-146a Plasma Levels Are Not Altered in Alzheimer's Disease but Correlate With Age and Illness Severity 119
Myeloid microvesicles in CSF are associated with myelin damage and neuronal loss in mild cognitive impairment and alzheimer disease. 116
Plasma Aβ42 as Biomarker of Prodromal Alzheimer's Disease Progression in Patients with Amnestic Mild Cognitive Impairment: Evidence from the PharmaCog/E-ADNI Study 114
Molecular mechanisms of brain stimulation. (Chapter 11). 110
Genetic determinants of circulating VEGF levels in major depressive disorder and electroconvulsive therapy response 102
Alterations observed in the interferon α and β signaling pathway in MDD patients are marginally influenced by cis-acting alleles 97
A machine learning approach on whole blood immunomarkers to identify an inflammation-associated psychosis onset subgroup. 81
Classification of Psychoses Based on Immunological Features: A Machine Learning Study in a Large Cohort of First-Episode and Chronic Patients 80
Inflammation-related microRNAs are involved in stressful life events exposure and in trauma-focused psychotherapy in treatment-resistant depressed patients 67
Schizophrenia risk conferred by rare protein-truncating variants is conserved across diverse human populations 62
Clinical validation of a combinatorial PharmAcogeNomic approach in major Depressive disorder: an Observational prospective RAndomized, participant and rater-blinded, controlled trial (PANDORA trial) 61
P.264 Association of single nucleotide polymorphisms in the 3’ untranslated region of SLC1A2 with major depressive disorder and relative endophenotypes 57
Vascular endothelial growth factor (VEGF) serum: putative predictive biomarkers for the electroconvulsive therapy (ECT) in depressed patients 45
Reduction of oxytocin plasma levels in borderline personality disorder and normalization induced by psychotherapies 26
Plasma microRNA Levels After Electroconvulsive Therapy in Treatment-Resistant Depressed Patients 15
Can We Modulate Our Second Brain and Its Metabolites to Change Our Mood? A Systematic Review on Efficacy, Mechanisms, and Future Directions of "Psychobiotics" 12
null 5
null 2
null 1
null 1
null 1
Totale 17.109
Salva come PNG Salva come JPEG
Categoria #
all - tutte 85.204
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 85.204
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.492 0 294 248 400 288 243 322 142 125 116 247 67
2021/2022598 108 59 128 46 9 21 21 139 33 23 8 3
2022/20231.614 176 11 11 221 167 344 1 230 299 43 87 24
2023/2024558 27 40 62 68 59 86 21 10 0 16 5 164
2024/20254.245 34 22 18 3 113 319 2.282 779 302 62 183 128
2025/2026283 181 102 0 0 0 0 0 0 0 0 0 0
Totale 17.109